Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr

Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr

By: IPP Bureau

Last updated : May 26, 2022 3:12 pm



The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.


Strides Pharma Science Limited has posted net profit of Rs. 29.21 crores for the period ended March 31, 2022 as against net loss of Rs. 121.671 crores for the period ended December 31, 2021. The company posted net profit of Rs.46.086 crores for the period ended March 31, 2021.

The company has reported total income of Rs. 952.07 crores during the period ended March 31, 2022 as compared to Rs. 804.58 crores during the period ended December 31, 2021. It reported total income of Rs.921.541 crores during the period ended March 31, 2021.

The company has reported total income of Rs.3202.23 crores during the Financial Year ended March 31, 2022 as compared to Rs.3367.29 crores during the Financial Year ended March 31, 2021.

The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022 as against net profit of Rs.268.44 crores for the Financial Year ended March 31, 2021.

Strides Pharma Science Limited

First Published : May 26, 2022 12:00 am